These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 26908579)

  • 1. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1.
    Wang H; Shi Y; Song J; Qi J; Lu G; Yan J; Gao GF
    Cell; 2016 Jan; 164(1-2):258-268. PubMed ID: 26771495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus entry requires the host-programmed recognition of an intracellular receptor.
    Miller EH; Obernosterer G; Raaben M; Herbert AS; Deffieu MS; Krishnan A; Ndungo E; Sandesara RG; Carette JE; Kuehne AI; Ruthel G; Pfeffer SR; Dye JM; Whelan SP; Brummelkamp TR; Chandran K
    EMBO J; 2012 Apr; 31(8):1947-60. PubMed ID: 22395071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
    Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
    mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
    Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF
    J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
    Front Immunol; 2021; 12():729851. PubMed ID: 34721393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
    Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
    mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
    J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
    Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
    J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
    Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
    Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses.
    Wec AZ; Nyakatura EK; Herbert AS; Howell KA; Holtsberg FW; Bakken RR; Mittler E; Christin JR; Shulenin S; Jangra RK; Bharrhan S; Kuehne AI; Bornholdt ZA; Flyak AI; Saphire EO; Crowe JE; Aman MJ; Dye JM; Lai JR; Chandran K
    Science; 2016 Oct; 354(6310):350-354. PubMed ID: 27608667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
    Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
    Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
    Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
    Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.
    Ng M; Ndungo E; Jangra RK; Cai Y; Postnikova E; Radoshitzky SR; Dye JM; Ramírez de Arellano E; Negredo A; Palacios G; Kuhn JH; Chandran K
    Virology; 2014 Nov; 468-470():637-646. PubMed ID: 25310500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filovirus entry: a novelty in the viral fusion world.
    Hunt CL; Lennemann NJ; Maury W
    Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.
    Koellhoffer JF; Chen G; Sandesara RG; Bale S; Saphire EO; Chandran K; Sidhu SS; Lai JR
    Chembiochem; 2012 Nov; 13(17):2549-57. PubMed ID: 23111988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.